Role of immunotherapy in gastric cancer with liver metastasis

被引：0
作者：
Gafton, Bogdan [1 ,2 ]
Morarasu, Stefan [3 ]
Dimofte, Gabriel [4 ]
机构：
[1] Reg Inst Oncol, Dept Oncol, Iasi 700483, Romania
[2] Grigore T Popa Univ Med & Pharm, Dept Oncol, Iasi 700115, Romania
[3] Grigore T Popa Univ Med & Pharm, Reg Inst Oncol, Fac Med, Dept Surg Oncol 2, Str Univ 16, Iasi 700115, Romania
[4] Univ Med & Pharm Grigore T Popa Iasi, Reg Inst Oncol Iasi, Dept Surg, Iasi 700483, Romania
来源：
WORLD JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 15卷 / 11期
关键词：
Gastric cancer; Immunotherapy; Liver metastases; Metastatic gastric cancer; Oncology; Surgical oncology; PLUS CHEMOTHERAPY; MULTICENTER;
D O I：
10.5306/wjco.v15.i11.1383
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Gastric cancer continues to be a significant issue for public health, marked by its widespread occurrence and high mortality rates, even as the incidence of the disease shows a declining trend. The liver is the primary site for metastatic spread, with the peritoneum, lungs, and bones also being common targets. With the advent of biologic treatments and the introduction of immunotherapy for patients with metastatic conditions, the options to treat metastatic gastric cancer have expanded. This diversified therapeutic approach is designed to enhance patient quality of life and prolong survival, showcasing the progress in treatment modalities for individuals with gastric cancer and liver metastases.
引用
收藏
页数：8
相关论文
共 34 条
  • [1] Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors A Nonrandomized Controlled Trial
    Andre, Thierry
    Berton, Dominique
    Curigliano, Giuseppe
    Sabatier, Renaud
    Tinker, Anna V.
    Oaknin, Ana
    Ellard, Susan
    de Braud, Filippo
    Arkenau, Hendrik-Tobias
    Trigo, Jose
    Gravina, Adriano
    Kristeleit, Rebecca
    Moreno, Victor
    Abdeddaim, Cyril
    Vano, Yann-Alexandre
    Samouelian, Vanessa
    Miller, Rowan
    Boni, Valentina
    Torres, Antonio Anton
    Gilbert, Lucy
    Brown, Jubilee
    Dewal, Ninad
    Dabrowski, Christine
    Antony, Grace
    Zografos, Eleftherios
    Veneris, Jennifer
    Banerjee, Susana
    [J]. JAMA NETWORK OPEN, 2023, 6 (11) : E2341165
  • [2] Bang YJ, 2010, LANCET, V376, P1302
  • [3] CAR-T Cell Therapy-An Overview of Targets in Gastric Cancer
    Bebnowska, Dominika
    Grywalska, Ewelina
    Niedzwiedzka-Rystwej, Paulina
    Sosnowska-Pasiarska, Barbara
    Smok-Kalwat, Jolanta
    Pasiarski, Marcin
    Gozdz, Stanislaw
    Rolinski, Jacek
    Polkowski, Wojciech
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 15
  • [4] Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor (CAR) for tumor immunotherapy; recent progress
    Budi, Hendrik Setia
    Ahmad, Firdaus Nuri
    Achmad, Harun
    Ansari, Mohammad Javed
    Mikhailova, Maria Vladimirovna
    Suksatan, Wanich
    Chupradit, Supat
    Shomali, Navid
    Marofi, Faroogh
    [J]. STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
  • [5] Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer
    Deng, Jia-Yi
    Gou, Qing
    Yang, Lingling
    Chen, Zhi-Hong
    Yang, Ming-Yi
    Yang, Xiao-Rong
    Yan, Hong-Hong
    Wei, Xue-Wu
    Liu, Jia-Qi
    Su, Jian
    Zhong, Wen-Zhao
    Xu, Chong-Rui
    Wu, Yi-Long
    Zhou, Qing
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (07)
  • [6] Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
    Durgeau, Aurelie
    Virk, Yasemin
    Corgnac, Stephanie
    Mami-Chouaib, Fathia
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [7] Current progress and challenges of immunotherapy in gastric cancer: A focus on CAR-T cells therapeutic approach
    Entezam, Mahshad
    Sanaei, Mohammad-Javad
    Mirzaei, Yousef
    Mer, Ali Hussein
    Abdollahpour-Alitappeh, Meghdad
    Azadegan-Dehkordi, Fatemeh
    Bagheri, Nader
    [J]. LIFE SCIENCES, 2023, 318
  • [8] Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial
    Fuchs, Charles S.
    Ozguroglu, Mustafa
    Bang, Yung-Jue
    Di Bartolomeo, Maria
    Mandala, Mario
    Ryu, Min-Hee
    Fornaro, Lorenzo
    Olesinski, Tomasz
    Caglevic, Christian
    Chung, Hyun C.
    Muro, Kei
    Van Cutsem, Eric
    Elme, Anneli
    Thuss-Patience, Peter
    Chau, Ian
    Ohtsu, Atsushi
    Bhagia, Pooja
    Wang, Anran
    Shih, Chie-Schin
    Shitara, Kohei
    [J]. GASTRIC CANCER, 2022, 25 (01) : 197 - 206
  • [9] Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial
    Fuchs, Charles S.
    Doi, Toshihiko
    Jang, Raymond W.
    Muro, Kei
    Satoh, Taroh
    Machado, Manuela
    Sun, Weijing
    Jalal, Shadia I.
    Shah, Manish A.
    Metges, Jean-Phillipe
    Garrido, Marcelo
    Golan, Talia
    Mandala, Mario
    Wainberg, Zev A.
    Catenacci, Daniel V.
    Ohtsu, Atsushi
    Shitara, Kohei
    Geva, Ravit
    Bleeker, Jonathan
    Ko, Andrew H.
    Ku, Geoffrey
    Philip, Philip
    Enzinger, Peter C.
    Bang, Yung-Jue
    Levitan, Diane
    Wang, Jiangdian
    Rosales, Minori
    Dalal, Rita P.
    Yoon, Harry H.
    [J]. JAMA ONCOLOGY, 2018, 4 (05)
  • [10] Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)
    Fukuoka, Shota
    Hara, Hiroki
    Takahashi, Naoki
    Kojima, Takashi
    Kawazoe, Akihito
    Asayama, Masako
    Yoshii, Takako
    Kotani, Daisuke
    Tamura, Hitomi
    Mikamoto, Yuichi
    Hirano, Nami
    Wakabayashi, Masashi
    Nomura, Shogo
    Sato, Akihiro
    Kuwata, Takeshi
    Togashi, Yosuke
    Nishikawa, Hiroyoshi
    Shitara, Kohei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (18) : 2053 - +
1234